Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT

BLOOD(2024)

引用 1|浏览4
暂无评分
摘要
This study presents a novel reverse-engineering approach to generate recombinant anti-PF4 antibodies from VITT-patient sera. These antibodies recapitulate functional effects of original serum anti-PF4 clonotypes, identify key PF4 binding residues and hold promise as valuable tools to investigate VITT etiology.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要